tirzepatide with phentermine and Together: Safety Guide Tirzepatide and Phentermine Together: Safety

By identifying potential risks, healthcare providers can modify treatment plans or suggest safer alternatives, such as semaglutide or other tailored weight loss solutions

On the same day, the FDA issued an additional label update highlighting those using semaglutide in combination with an insulin secretagogue or insulin may have an increased risk of hypoglycemia, including severe hypoglycemia, with new labeling information suggesting those initiating semaglutide use should consider reducing the dose of concomitantly administered insulin secretagogue, such as sulfonylureas or insulin, to reduce the risk of hypoglycemia

If you are using oral hormonal contraceptives, add a non-oral contraceptive method or a barrier method of contraception for 4 weeks after starting medication and for 4 weeks after each dose increase

Semaglutide (Wegovy/Ozempic) to tirzepatide (Zepbound/Mounjaro) approximate equivalencies Notice something important in that chart

California Proposition 65 WARNING: Consuming this product can expose you to chemicals including lead and cadmium which are known to the State of California to cause cancer and birth defects or other reproductive harm

Curr Opin Behav Sci (2017) 13:349